文献速递乳腺癌支持与姑息治疗

运动与营养干预对乳腺癌患者化疗完成度和病理完全缓解的随机试验:生活方式、运动与营养早期诊断后研究

Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study.
PubMed 文献 · J Clin Oncol · 2023-09-01

该随机试验纳入173例I-III期乳腺癌患者,随机分为常规护理组(86例)或家庭运动与营养干预组(87例)。干预组运动及饮食质量改善优于常规护理组(P<.05),但两组相对剂量强度(RDI)无显著差异(92.9%±12.1% vs 93.6%±11.1%,P=.69)。在接受新辅助化疗的72例患者中,干预组病理完全缓解(pCR)率高于常规护理组(53% vs 28%,P=.037)。

要点

  • 运动与营养干预未显著影响乳腺癌患者化疗相对剂量强度。
  • 干预组运动及饮食质量改善优于常规护理组(P<.05)。
  • 新辅助化疗患者中干预组pCR率高于常规护理组(53% vs 28%,P=.037)。

核心结论

  • 饮食与运动干预未影响RDI,但与接受新辅助化疗的激素受体阳性/人表皮生长因子受体2阴性及三阴性乳腺癌患者更高的pCR相关。

研究设计与样本

  • 随机试验纳入173例I-III期乳腺癌患者,随机分为常规护理组(n=86)或家庭运动与营养干预组(n=87),干预由肿瘤认证注册营养师提供咨询。
  • 化疗剂量调整、延迟及pCR从电子病历中提取,采用t检验和卡方检验比较干预组与常规护理组的RDI和pCR。

主要发现

  • 干预组运动及饮食质量改善优于常规护理组(P<.05)。
  • 干预组与常规护理组RDI分别为92.9%±12.1%与93.6%±11.1%(P=.69)。
  • 干预组与常规护理组达到≥85% RDI的患者比例分别为81%与85%(P=.44)。
  • 干预组与常规护理组至少一次剂量减少和/或延迟的患者比例分别为38%与36%(P=.80)。
  • 接受新辅助化疗的72例患者中,干预组pCR率高于常规护理组(53% vs 28%,P=.037)。

关键数值与推荐

  • RDI定义为实际化疗剂量与处方剂量的比值。
  • 干预组与常规护理组RDI分别为92.9%±12.1%与93.6%±11.1%(P=.69)。
  • 干预组与常规护理组达到≥85% RDI的患者比例分别为81%与85%(P=.44)。
  • 接受新辅助化疗的72例患者中,干预组pCR率53%,常规护理组28%(P=.037)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Successful completion of chemotherapy is critical to improve breast cancer outcomes. Relative dose intensity (RDI), defined as the ratio of chemotherapy delivered to prescribed, is a measure of chemotherapy completion and is associated with cancer mortality. The effect of exercise and eating a healthy diet on RDI is unknown. We conducted a randomized trial of an exercise and nutrition intervention on RDI and pathologic complete response (pCR) in women diagnosed with breast cancer initiating chemotherapy. METHODS: One hundred seventy-three women with stage I-III breast cancer were randomly assigned to usual care (UC; n = 86) or a home-based exercise and nutrition intervention with counseling sessions delivered by oncology-certified registered dietitians (n = 87). Chemotherapy dose adjustments and delays and pCR were abstracted from electronic medical records. T-tests and chi-square tests were used to examine the effect of the intervention versus UC on RDI and pCR. RESULTS: Participants randomly assigned to intervention had greater improvements in exercise and diet quality compared with UC (P < .05). RDI was 92.9% ± 12.1% and 93.6% ± 11.1% for intervention and UC, respectively (P = .69); the proportion of patients in the intervention versus UC who achieved ≥85% RDI was 81% and 85%, respectively (P = .44). The proportion of patients who had at least one dose reduction and/or delay was 38% intervention and 36% UC (P = .80). Among 72 women who received neoadjuvant chemotherapy, women randomly assigned to intervention were more likely to have a pCR than those randomly assigned to UC (53% v 28%; P = .037). CONCLUSION: Although a diet and exercise intervention did not affect RDI, the intervention was associated with a higher pCR in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative and triple-negative breast cancer undergoing neoadjuvant chemotherapy.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Sanft T, Harrigan M, McGowan C, et al. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. J Clin Oncol. 2023. PMID: 37656930. doi:10.1200/JCO.23.00871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。